Cell-based influenza vaccine: current production, halal status assessment, and recommendations towards Islamic-compliant manufacturing

References

• Riedel S. Edward Jenner and the history of smallpox and vaccination. Baylor Univ Med Cent Proc. 2005;18(1):21–25. PMID: 16200144. doi:10.1080/08998280.2005.11928028.
   PubMedGoogle Scholar
• Greenwood B. The contribution of vaccination to global health: past, present and future. Philos Trans R Soc L B Biol Sci. 2014;369(1645):20130433. PMID: 24821919. doi:10.1098/rstb.2013.0433.
   PubMed Web of Science ®Google Scholar
• Ahmed A, Lee KS, Bukhsh A, Al-Worafi YM, Sarker MMR, Ming LC, Khan TM. Outbreak of vaccine-preventable diseases in Muslim majority countries. J Infect Public Heal. 2018;11(2):153–55. PMID: 28988775. doi:10.1016/j.jiph.2017.09.007.
   PubMed Web of Science ®Google Scholar
• Khoo YSK, Ghani AA, Navamukundan AA, Jahis R, Gamil A. Unique product quality considerations in vaccine development, registration and new program implementation in Malaysia. Hum Vaccin Immunother. 2020;16(3):530–38. PMID: 31652090. doi:10.1080/21645515.2019.1667206.
   PubMed Web of Science ®Google Scholar
• Zarif MMM, Murad A, Yusof AM. The use of forbidden materials in medicinal products: an Islamic perspective. Middle-East J Sci Res. 2013;13(Approachesof Halal and Thoyyib for Society, Wellness and Health):5–10. doi:10.5829/idosi.mejsr.2013.16.s.10022.
   Google Scholar
• Padela AI, Furber SW, Kholwadia MA, Moosa E. Dire necessity and transformation: entry-points for modern science in Islamic bioethical assessment of porcine products in vaccines. Bioethics. 2014;28(2):59–66. doi:10.1111/bioe.12016.
   PubMed Web of Science ®Google Scholar
• Department of Standards Malaysia (STANDARDS MALAYSIA). Halal pharmaceuticals - general requirements (first revision) MS2424:2019. Cyberjaya (Malaysia): Department of Standards Malaysia; 2019.
   Google Scholar
• Thomson Reuters, Dinar Standard. An inclusive ethical economy: state of the global Islamic economy report 2018/19. Dubai (UAE): Thomson Reuters; 2018. [accessed 2019 Sep 29]. https://haladinar.io/hdn/doc/report2018.pdf
   Google Scholar
• World Health Organization (WHO). Influenza (Seasonal). 2018 Nov 6 [accessed 2019 Aug 26]. https://www.who.int/en/news-room/fact-sheets/detail/influenza-(seasonal)
   Google Scholar
• Balkhy HH, Memish ZA, Bafaqeer S, Almuneef MA. Influenza a common viral infection among Hajj pilgrims: time for routine surveillance and vaccination. J Travel Med. 2004;11(2):82–86. PMID: 15109471. doi:10.2310/7060.2004.17027.
   PubMed Web of Science ®Google Scholar
• Gregersen JP, Schmitt HJ, Trusheim H, Bröker M. Safety of MDCK cell culture-based influenza vaccines. Futur Microbiol. 2011;6(2):143–52. PMID: 21366415. doi:10.2217/fmb.10.161.
   PubMed Web of Science ®Google Scholar
• Huang D, Peng WJ, Ye Q, Liu XP, Zhao L, Fan L, Xia-Hou K, Jia HJ, Luo J, Zhou LT, et al. Serum-free suspension culture of MDCK cells for production of influenza H1N1 vaccines. PLoS One. 2015;10(11):e0141686. PMID: 26540170. doi:10.1371/journal.pone.0141686.
   PubMed Web of Science ®Google Scholar
• Hu AY, Tseng YF, Weng TC, Liao CC, Wu J, Chou AH, Chao HJ, Gu A, Chen J, Lin SC, et al. Production of inactivated influenza H5N1 vaccines from MDCK cells in serum-free medium. PLoS One. 2011;6(1): e14578. PMID: 21283675. doi:10.1371/journal.pone.0014578.
   Web of Science ®Google Scholar
• Genzel Y, Dietzsch C, Rapp E, Schwarzer J, Reichl U. MDCK and Vero cells for influenza virus vaccine production: a one-to-one comparison up to lab-scale bioreactor cultivation. Appl Microbiol Biotechnol. 2010;88(2):461–75. PMID: 20617311. doi:10.1007/s00253-010-2742-9.
   PubMed Web of Science ®Google Scholar
• Offit PA, Jew RK. Addressing parents’ concerns: do vaccines contain harmful preservatives, adjuvants, additives, or residuals? Pediatrics. 2003;112(6 Pt 1):1394–97. PMID: 14654615. doi:10.1542/peds.112.6.1394.
   PubMed Web of Science ®Google Scholar
• Finn TM, Egan W. Vaccine additives and manufacturing residuals in vaccines licensed in the United States. In: Plotkin SA, Orenstein WA, Offit PA, Edwards KM, editors. Plotkin’s vaccines. 7th ed. Philadelphia (PA): Elsevier; 2018. p. 75–83.e2. doi:10.1016/B978-0-323-35761-6.00007-9
   Google Scholar
• Eisfeld AJ, Neumann G, Kawaoka Y. Influenza A virus isolation, culture and identification. Nat Protoc. 2014;9(11):2663–81. PMID: 25321410. doi:10.1038/nprot.2014.180.
   PubMed Web of Science ®Google Scholar
• Besnard L, Fabre V, Fettig M, Gousseinov E, Kawakami Y, Laroudie N, Scanlan C, Pattnaik P. Clarification of vaccines: an overview of filter based technology trends and best practices. Biotechnol Adv. 2016;34(1):1–13. PMID: 26657051. doi:10.1016/j.biotechadv.2015.11.005.
   PubMed Web of Science ®Google Scholar
• Wolff MW, Reichl U. Downstream processing of cell culture-derived virus particles. Expert Rev Vaccines. 2011;10(10):1451–75. PMID: 21988309. doi:10.1586/erv.11.111.
   PubMed Web of Science ®Google Scholar
• Josefsberg JO, Buckland B. Vaccine process technology. Biotechnol Bioeng. 2012;109(6):1443–60. PMID: 22407777. doi:10.1002/bit.24493.
   PubMed Web of Science ®Google Scholar
• Cardoso FMC, Petrovajová D, Horňáková T. Viral vaccine stabilizers: status and trends. Acta Virol. 2017;61(3):231–39. PMID: 28854787. doi:10.4149/av_2017_301.
   PubMed Web of Science ®Google Scholar
• Soema PC, Kompier R, Amorij JP, Kersten GF. Current and next generation influenza vaccines: formulation and production strategies. Eur J Pharm Biopharm PMID: 26047796. 2015;94:251–63. doi:10.1016/j.ejpb.2015.05.023.
   PubMed Web of Science ®Google Scholar
• Amorij JP, Huckriede A, Wilschut J, Frijlink HW, Hinrichs WL. Development of stable influenza vaccine powder formulations: challenges and possibilities. Pharm Res. 2008;25(6):1256–73. PMID: 18338241. doi:10.1007/s11095-008-9559-6.
   PubMed Web of Science ®Google Scholar
• Hankaniemi MM, Laitinen OH, Stone VM, Sioofy-Khojine A, Määttä JAE, Larsson PG, Marjomäki V, Hyöty H, Flodström-Tullberg M, Hytönen VP. Optimized production and purification of Coxsackievirus B1 vaccine and its preclinical evaluation in a mouse model. Vaccine. 2017;35(30):3718–25. PMID: 28579231. doi:10.1016/j.vaccine.2017.05.057.
   PubMed Web of Science ®Google Scholar
• Ersahin ME, Ozgun H, Dereli RK, Ozturk I, Roest K, van Lier JB. A review on dynamic membrane filtration: materials, applications and future perspectives. Bioresour Technol PMID: 22534368. 2012;122:196–206. doi:10.1016/j.biortech.2012.03.086.
   PubMed Web of Science ®Google Scholar
• Zhao M, Vandersluis M, Stout J, Haupts U, Sanders M, Jacquemart R. Affinity chromatography for vaccines manufacturing: finally ready for prime time? Vaccine. 2019;37(36):5491–503. PMID: 29627235. doi:10.1016/j.vaccine.2018.02.090.
   PubMed Web of Science ®Google Scholar
• Salleh MMM, Deuraseh N, Subri IM, Rahman SA, Mustafa S, Jamaludin MA, Safian YHM. The use of ceramic product derived from non-ḥalal animal bone: is it permissible from the perspective of Islamic law? Int J Asian Soc Sci. 2017;7(3):192–98. doi:10.18488/journal.1/2017.7.3/1.3.192.198.
   Google Scholar
• Cassano A, Basile A. Membranes for industrial microfiltration and ultrafiltration. In: Basile A, Nunes SP, editors. Advanced membrane science and technology for sustainable energy and environmental applications. Cambridge (UK): Woodhead Publishing; 2011. p. 647–79. doi:10.1533/9780857093790.5.647.
   Google Scholar
• World Health Organization. Cell culture as a substrate for the production of influenza vaccines: memorandum from a WHO meeting. Bull World Heal Organ. 1995;73(4): 431–35. PMID: 7554013.
   PubMed Web of Science ®Google Scholar
• Ab Halim MAB, Kashim MIABM, Salleh MMM, Nordin NB, Husni ABM. Halal pharmaceuticals. The Soc Sci. 2015;10(4):490–98. doi:10.3923/sscience.2015.490.498.
   Google Scholar
• Tuan Sidek TM, Ridzwan A. Aplikasi najis mughallazah dalam penetapan halal semasa di Malaysia menurut perspektif Maqasid al-Shariah [Applications of severe najs in determining the current halal in Malaysia according to Maqasid al-Shariah perspective]. J AL-ANWAR, Persat Bek Mhs Islam Timur. 2018; 5(1):1–21. [accessed 2019 Jun 18]. https://umexpert.um.edu.my/file/publication/00002816_165228_77194.pdf.
   Google Scholar
• Food and Drug Administration (FDA). Guidance for industry: characterization and qualification of cell substrates and other biological materials used in the production of viral vaccines for infectious disease indications. 2010 Feb [accessed 2019 Jun 20]. http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/default.htm
   Google Scholar
• World Health Organization (WHO). Recommendations for the evaluation of animal cell cultures as substrates for the manufacture of biological medicinal products and for the characterization of cell banks. Annex 3. In: WHO Expert Committee on Biological Standardization. Sixty first report. WHO technical report series. No. 978. Geneva (Switzerland): WHO Press; 2010. [accessed 2019 Jun 20]. https://www.who.int/biologicals/Cell_Substrates_clean_version_18_April.pdf
   Google Scholar
• Hess RD, Weber F, Watson K, Schmitt S. Regulatory, biosafety and safety challenges for novel cells as substrates for human vaccines. Vaccine. 2012;30(17):2715–27. PMID: 22342707. doi:10.1016/j.vaccine.2012.02.015.
   PubMed Web of Science ®Google Scholar
• Sheng-Fowler L, Lewis AM, Peden K. Issues associated with residual cell-substrate DNA in viral vaccines. Biologicals. 2009;37(3):190–95. PMID: 19285882. doi:10.1016/j.biologicals.2009.02.015.
   PubMed Web of Science ®Google Scholar
• Peden K, Sheng L, Pal A, Lewis A. Biological activity of residual cell-substrate DNA. Dev Biol (Basel). 2006;123:45–53. PMID: 16566436.
   PubMedGoogle Scholar
• Wang X, Hunter AK, Mozier NM. Host cell proteins in biologics development: identification, quantitation and risk assessment. Biotechnol Bioeng. 2009;103(3):446–58. PMID: 19388135. doi:10.1002/bit.22304.
   PubMed Web of Science ®Google Scholar
• Le Ru A, Jacob D, Transfiguracion J, Ansorge S, Henry O, Kamen AA. Scalable production of influenza virus in HEK-293 cells for efficient vaccine manufacturing. Vaccine. 2010;28(21):3661–71. PMID: 20347632. doi:10.1016/j.vaccine.2010.03.029.
   PubMed Web of Science ®Google Scholar
• Pau MG, Ophorst C, Koldijk MH, Schouten G, Mehtali M, Uytdehaag F. The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines. Vaccine. 2001;19(17–19):2716–21. PMID: 11257414. doi:10.1016/s0264-410x(00)00508-9.
   PubMed Web of Science ®Google Scholar
• van Wielink R, Kant-Eenbergen HCM, Harmsen MM, Martens DE, Wijffels RH, Coco-Martin JM. Adaptation of a Madin-Darby canine kidney cell line to suspension growth in serum-free media and comparison of its ability to produce avian influenza virus to Vero and BHK21 cell lines. J Virol Methods. 2011;171(1):53–60. PMID: 20933017. doi:10.1016/j.jviromet.2010.09.029.
   PubMed Web of Science ®Google Scholar
• Genzel Y. Designing cell lines for viral vaccine production: where do we stand? Biotechnol J. 2015;10(5):728–40. PMID: 25903999. doi:10.1002/biot.201400388.
   PubMed Web of Science ®Google Scholar
• White KM, Ayllon J, Mena I, Potenski A, Krammer F, García-Sastre A. Influenza B virus reverse genetic backbones with improved growth properties in the EB66® cell line as basis for vaccine seed virus generation. Vaccine. 2018;36(9):1146–53. PMID: 29395518. doi:10.1016/j.vaccine.2018.01.050.
   PubMed Web of Science ®Google Scholar
• Lohr V, Rath A, Genzel Y, Jordan I, Sandig V, Reichl U. New avian suspension cell lines provide production of influenza virus and MVA in serum-free media: studies on growth, metabolism and virus propagation. Vaccine. 2009;27(36):4975–82. PMID: 19531390. doi:10.1016/j.vaccine.2009.05.083.
   PubMed Web of Science ®Google Scholar
• Petiot E, Proust A, Traversier A, Durous L, Dappozze F, Gras M, Guillard C, Balloul JM, Rosa-Calatrava M. Influenza viruses production: evaluation of a novel avian cell line DuckCelt®-T17. Vaccine. 2018;36(22):3101–11. PMID: 28571695. doi:10.1016/j.vaccine.2017.03.102.
   PubMed Web of Science ®Google Scholar
• Coussens PM, Smith KA, Weber PSD, Colvin CJ. Immortalized chick embryo cell line adapted to serum-free growth conditions and capable of replicating human and reassortant H5N1 influenza strains for vaccine production. Vaccine. 2011;29(47):8661–68. PMID: 21911025. doi:10.1016/j.vaccine.2011.08.122.
   PubMed Web of Science ®Google Scholar
• Cox MMJ, Anderson DK. Production of a novel influenza vaccine using insect cells: protection against drifted strains. Influenza Other Respi Viruses. 2007;1(1):35–40. PMID: 19453478. doi:10.1111/j.1750-2659.2006.00007.x.
   PubMed Web of Science ®Google Scholar
• Jamaludin MA, Ramli MA, Rahman SA Panduan makanan halal haram menurut perspektif al-Quran: analisis terhadap isu-isu makanan semasa [Guidelines of halal haram food according to al-Quran perspective: analysis on current food issues]. In: International Seminar on Wahyu Asas Tamadun 2; 2011; Nilai, Malaysia. p. 1–15.
   Google Scholar
• Regenstein JM, Chaudry MM, Regenstein CE. The kosher and halal food laws. Compr Rev Food Sci Food Saf. 2003;2(3):111–27. doi:10.1111/j.1541-4337.2003.tb00018.x.
   PubMedGoogle Scholar
• Yao T, Asayama Y. Animal-cell culture media: history, characteristics, and current issues. Reprod Med Biol. 2017;16(2):99–117. PMID: 29259457. doi:10.1002/rmb2.12024.
   PubMed Web of Science ®Google Scholar
• van der Valk J, Brunner D, De Smet K, Fex Svenningsen Å, Honegger P, Knudsen LE, Lindl T, Noraberg J, Price A, Scarino ML, et al. Optimization of chemically defined cell culture media – replacing fetal bovine serum in mammalian in vitro methods. Toxicol Vitr. 2010;24(4):1053–63. doi:10.1016/j.tiv.2010.03.016.
   PubMed Web of Science ®Google Scholar
• Gstraunthaler G. Alternatives to the use of fetal bovine serum: serum-free cell culture. ALTEX. 2003;20(4):275–81. PMID: 14671707.
   PubMedGoogle Scholar
• Brunner D, Frank J, Appl H, Schöffl H, Pfaller W, Gstraunthaler G. Serum-free cell culture: the serum-free media interactive online database. ALTEX. 2010;27(1):53–62. doi:10.14573/altex.2010.1.53.
   PubMedGoogle Scholar
• Jochems CEA, Van der Valk JBF, Stafleu FR, Baumans V. The use of fetal bovine serum: ethical or scientific problem? ATLA Altern to Lab Anim. 2002;30(2):219–27. PMID: 11971757. doi:10.1177/026119290203000208.
   PubMed Web of Science ®Google Scholar
• Fletcher T, Harris H. Safety drives innovation in animal-component-free cell-culture media technology. BioPharm Int. 2016; 29(9):22–27. [accessed 2019 Mar 14]. http://www.biopharminternational.com/safety-drives-innovation-animal-component-free-cell-culture-media-technology.
   Web of Science ®Google Scholar
• Mohezar S, Zailani S, Tieman M. Tapping into the halal pharmaceutical market: issues and challenges. In: Ab. Manan SK, Abd Rahman F, Sahri M, editors. Contemporary issues and development in the global halal industry. Singapore: Springer Singapore; 2016. p. 531–41. doi:10.1007/978-981-10-1452-9_48.
   Google Scholar
• Kashim MIAM, Jamsari EA, Safiai MH, Adnan NIM, Safri LS. Genetic modified organisms (GMOs) from the perspective of science and Maqasid Shari‘ah. Int J Civ Eng Technol. 2018; 9(8):1381–93. [accessed 2020 Feb 14]. http://www.iaeme.com/ijciet/issues.asp?JType=IJCIET&VType=9&IType=8.
   Google Scholar
• Eagle H. Amino acid metabolism in mammalian cell cultures. Science (80-). 1959;130(3373):432–37. PMID: 13675766. doi:10.1126/science.130.3373.432.
   PubMed Web of Science ®Google Scholar
• Freshney RI. Defined media and supplements. In: Freshney RI, editor. Culture of animal cells. 5th ed. Hoboken (NJ): John Wiley & Sons; 2005. p. 115–28. doi:10.1002/0471747599.cac009
   Google Scholar
• Ermis E. Halal status of enzymes used in food industry. Trends Food Sci Technol. 2017;64:69–73. doi:10.1016/j.tifs.2017.04.008.
   Web of Science ®Google Scholar
• Karahalil E. Principles of halal-compliant fermentations: microbial alternatives for the halal food industry. Trends Food Sci Technol. 2020;98:1–9. doi:10.1016/j.tifs.2020.01.031.
   Web of Science ®Google Scholar
• D’Este M, Alvarado-Morales M, Angelidaki I. Amino acids production focusing on fermentation technologies – A review. Biotechnol Adv. 2018;36(1):14–25. PMID: 28888551. doi:10.1016/j.biotechadv.2017.09.001.
   PubMed Web of Science ®Google Scholar
• Lu Y, Wang L, Teng F, Zhang J, Hu M, Tao Y. Production of myo-inositol from glucose by a novel trienzymatic cascade of polyphosphate glucokinase, inositol 1-phosphate synthase and inositol monophosphatase. Enzyme Microb Technol PMID: 29499774. 2018;112:1–5. doi:10.1016/j.enzmictec.2018.01.006.
   PubMed Web of Science ®Google Scholar
• Lim SH, Choi JS, Park EY. Microbial production of riboflavin using riboflavin overproducers,Ashbya gossypii, Bacillus subtilis, and Candida famate: an overview. Biotechnol Bioprocess Eng. 2001;6(2):75–88. doi:10.1007/BF02931951.
   Google Scholar
• Acevedo-Rocha CG, Gronenberg LS, Mack M, Commichau FM, Genee HJ. Microbial cell factories for the sustainable manufacturing of B vitamins. Curr Opin Biotechnol PMID: 30138794. 2019;56:18–29. doi:10.1016/j.copbio.2018.07.006.
   PubMed Web of Science ®Google Scholar
• Mótyán JA, Tóth F, Tőzsér J. Research applications of proteolytic enzymes in molecular biology. Biomolecules. 2013;3(4):923–42. PMID: 24970197. doi:10.3390/biom3040923.
   PubMedGoogle Scholar
• Seitz C, Isken B, Heynisch B, Rettkowski M, Frensing T, Reichl U. Trypsin promotes efficient influenza vaccine production in MDCK cells by interfering with the antiviral host response. Appl Microbiol Biotechnol. 2012;93(2):601–11. PMID: 21915610. doi:10.1007/s00253-011-3569-8.
   PubMed Web of Science ®Google Scholar
• Rourou S, van der Ark A, van der Velden T, Kallel H. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions. Vaccine. 2007;25(19):3879–89. doi:10.1016/j.vaccine.2007.01.086.
   PubMed Web of Science ®Google Scholar
• Nestler L, Evege E, Mclaughlin J, Munroe D, Tan T, Wagner K, Stiles B. TrypLE TM Express: A temperature stable replacement for animal trypsin in cell dissociation applications. QUEST. 2004; 1(1):42–47. [accessed 2019 Feb 20]. https://pdfs.semanticscholar.org/6c6b/b1d2772ffccd0f004135dbf07bc1750feecd.pdf.
   Google Scholar
• Manira M, Khairul Anuar K, Seet WT, Ahmad Irfan AW, Ng MH, Chua KH, Mohd Heikal MY, Aminuddin BS, Ruszymah BHI. Comparison of the effects between animal-derived trypsin and recombinant trypsin on human skin cells proliferation, gene and protein expression. Cell Tissue Bank. 2014;15(1):41–49. PMID: 23456438. doi:10.1007/s10561-013-9368-y.
   PubMed Web of Science ®Google Scholar
• Tsuji K, Ojima M, Otabe K, Horie M, Koga H, Sekiya I, Muneta T. Effects of different cell-detaching methods on the viability and cell surface antigen expression of synovial mesenchymal stem cells. Cell Transplant. 2017;26(6):1089–102. PMID: 28139195. doi:10.3727/096368917x694831.
   PubMed Web of Science ®Google Scholar
• Nacalai Tesque. Cell dissociation reagents (accutase). [accessed 2019 Jul 9]. https://www.nacalai.co.jp/global/reagent/research/Accutase.html
   Google Scholar
• Sigma-Aldrich. Accutase ® solution. 2019 [accessed 2019 Jul 9]. https://www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/Sigma/Datasheet/6/a6964dat.pdf
   Google Scholar
• Corning. Accutase ® cell detachment solution. 2015 [accessed 2019 Jul 4]. www.corning.com/lifesciences
   Google Scholar
• Biological Industries. Accutase. 2014 Jan [accessed 2019 Jul 9]. https://www.bioind.com/media/wysiwyg/product/cell-culture-reagents/Accutase-cell-dissociation.pdf
   Google Scholar
• Skog M, Sivlér P, Steinvall I, Aili D, Sjöberg F, Elmasry M. The effect of enzymatic digestion on cultured epithelial autografts. Cell Transplant. 2019;28(5):638–44. PMID: 30983404. doi:10.1177/0963689719833305.
   PubMed Web of Science ®Google Scholar
• Bajpai R, Lesperance J, Kim M, Terskikh AV. Efficient propagation of single cells accutase-dissociated human embryonic stem cells. Mol Reprod Dev. 2008;75(5):818–27. doi:10.1002/mrd.20809.
   PubMed Web of Science ®Google Scholar
• Azmi MAI Kesan enzim proteolitik berbeza terhadap infektiviti virus influenza B ke atas kultur sel mamalia untuk penghasilan vaksin patuh syariah [Effect of different proteolytic enzymes on the infectivity of influenza B virus in mammalian cell culture for production of sharia-compliance virus vaccines] [BEng. thesis]. Bangi (Malaysia): Universiti Kebangsaan Malaysia; 2019.
   Google Scholar
• Kumru OS, Joshi SB, Smith DE, Middaugh CR, Prusik T, Volkin DB. Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies. Biologicals. 2014;42(5):237–59. PMID: 24996452. doi:10.1016/j.biologicals.2014.05.007.
   PubMed Web of Science ®Google Scholar
• Batu A, Regenstein JM, Doğan İS. Gelatin issues in halal food processing for Muslim societies. Int Period Lang Lit Hist Turkish or Turkic. 2015;10(14):37–52. doi:10.7827/TurkishStudies.8928.
   Google Scholar
• Gomez-Guillen MC, Gimenez B, Lopez-Caballero ME, Montero MP. Functional and bioactive properties of collagen and gelatin from alternative sources: A review. Food Hydrocoll. 2011;25(8):1813–27. doi:10.1016/j.foodhyd.2011.02.007.
   Web of Science ®Google Scholar
• Rakhmanova A, Khan ZA, Sharif R, Lü X. Meeting the requirements of halal gelatin: a mini review. MOJ Food Process Technol. 2018;6(6):477–82. doi:10.15406/mojfpt.2018.06.00209.
   Google Scholar
• Gelatin Manufacturers Institute of America (GMIA). Gelatin handbook. 2019 [accessed 2020 Feb 13]. http://www.gelatin-gmia.com/uploads/1/1/8/4/118450438/gmia_gelatin_manual_2019.pdf
   Google Scholar
• Kashim MIAM. Istihalah dan kesannya kepada makanan menurut perspektif Islam [The effect of istihalah on food according to Islamic perspective]. J Soc Sci Humanit. 2017; 12(2):102–11. [accessed 2019 Mar 20]. http://ejournal.ukm.my/ebangi/article/viewFile/20398/6436.
   Google Scholar
• Grabenstein JD. What the world’s religions teach, applied to vaccines and immune globulins. Vaccine. 2013;31(16):2011–23. PMID: 23499565. doi:10.1016/j.vaccine.2013.02.026.
   PubMed Web of Science ®Google Scholar
• Abd Rahman N, Kamarudin NS, Esa F, Kalil MS, Kamarudin SK. Bacterial cellulose as a potential hard gelatin capsule. J Kejuruter. 2019;SI 2(1):151–56. doi:10.17576/jkukm-2019-si2(1)-19.
   Web of Science ®Google Scholar
• Whitford WG, Fairbank A. Considerations in scale-up of viral vaccine production. Bioprocess Int. 2011; 9(8):16–28. [accessed 2019 Jan 29]. https://bioprocessintl.com/manufacturing/monoclonal-antibodies/considerations-in-scale-up-of-viral-vaccine-production-320990/.
   Google Scholar
• Nilsson K. Microcarrier cell culture. Biotechnol Genet Eng Rev. 1988;6(1):403–39. PMID: 3071374. doi:10.1080/02648725.1988.10647854.
   PubMedGoogle Scholar
• Li B, Wang X, Wang Y, Gou W, Yuan X, Peng J, Guo Q, Lu S. Past, present, and future of microcarrier-based tissue engineering. J Orthop Transl. 2015;3(2):51–57. PMID: 30035040. doi:10.1016/j.jot.2015.02.003.
   PubMed Web of Science ®Google Scholar
• Hassan WMW. Globalising halal standards: issues and challenges. Halal J. 2007;38–40. [accessed 2020 Oct 14]. https://www.academia.edu/243214/Globalising_Halal_Standards_Issues_and_Challenges
   Google Scholar
• Mahyeddin MS, Afifi M, Halim A, Mahyeddin M, Salleh M. The possibility of uniformity on halal standards in organization of Islamic countries (OIC) country. World Appl Sci J. 2012; 17(Towardsthe Traceability of Halal and Thoyyiban Application):6–10. [accessed 2020 Oct 14]. http://ddms.usim.edu.my:80/jspui/handle/123456789/15369.
   Google Scholar
• Kashim MIAM, Majid LA, Adnan AHM, Husni ABM, Nasohah Z, Samsudin MA, Yahaya MZ. Principles regarding the use of haram (forbidden) sources in food processing: a critical Islamic analysis. Asian Soc Sci. 2015;11(22):17–25. doi:10.5539/ass.v11n22p17.
   Google Scholar
• Norazmi MN, Lim LS. Halal pharmaceutical industry: opportunities and challenges. Trends Pharmacol Sci. 2015;36(8):496–97. PMID: 26187623. doi:10.1016/j.tips.2015.06.006.
   PubMed Web of Science ®Google Scholar
• Abdullah AB. Challenges facing halal vaccine industry. New Straits Times. 2017 Apr 21. [accessed 2018 Aug 13. https://www.nst.com.my/opinion/columnist/2017/04/232513/challenges-facing-halal-vaccine-industry.
   Google Scholar
• Alzeer J. Halalopathy: A science of trust in medicine. J Integr Med. 2019;17(3):150–54. PMID: 30948352. doi:10.1016/j.joim.2019.03.005.
   PubMed Web of Science ®Google Scholar
• Basari H. New frontiers in halal pharmaceuticals. Int J Res Pharm Sci. 2019;10(SPL1). doi:10.26452/ijrps.v10ispl1.1687.
   Google Scholar